Fig. 4From: CXCL9 may serve as a potential biomarker for primary Sjögren’s syndrome with extra-glandular manifestationsDifferential expression of CXCL9 and CXCR3 in plasma. A, B Boxplots depicting the expression of plasma CXCL9 (A) and CXCR3 (B) in HC, non-pSS, pSS, SLE. C, D Boxplots showing the expression of plasma CXCL9 (C) and CXCR3 (D) between pSS-non-EGM and pSS-EGM. Significance determined by Wilcoxon's testBack to article page